Project Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model
Financial Entity: Instituto de Salud Carlos III (PI19/01266)
Lenght: 2020-2022
Principal Investigator: Jordi Muntané Relat
granted: 165.770,00 Euros
Network Title: Biología y Medicina Redox
Financial Entity: Convocatoria 2018 ‐ Acciones de dinamización «Redes de Investigación» (RED2018‐102576‐T)
Lenght: 2020-2021
Principal investigator: Juan Sastre Belloch
Granted: 20.500 Euros
Project Title: Aislamiento y criopreservación de hepatocitos humanos útiles para la validación de la actividad de los inhibidores de tirosina quinasa en el metabolismo celular y en los mecanismos de supervivencia y muerte celular
Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación e innovación colaboración público-privada (PIP-0215-2020)
Lenght: 2021-2023
Principal investigator: Miguel Ángel Gómez Bravo
granted: 243.788,50 Euros
Project title: Identificación del papel de miRNA y lncRNA en las células tumorales circulantes en la progresión y respuesta al tratamiento en pacientes con carcinoma hepatocelular en estadio intermedio y avanzado. Desarrollo de una nueva terapia experimental
Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación en salud (PI-0216-2020)
Lenght: 2021-2023
Principal Investigator: Jordi Muntané Relat, María Teresa Ferrer Ríos
Granted: 149.508,05 Euros
Project Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model
Financial Entity: Instituto de Salud Carlos III (PI19/01266)
Lenght: 2020-2022
Principal Investigator: Jordi Muntané Relat
Granted: 165.770,00 Euros
Project Title: Liquid Biopsy applied to the search for cellular and epigenetic markers for the development of diagnostic, prognostic and predictive tests in patients with hepatocarcinoma (PC-0033-2017)
Financial Entity: Consejería de Salud (Junta de Andalucía)
Other collaborating Entity: Genyo (Granada)
Lenght: 2018-2020
Principal Investigator: José Antonio Lorente Acosta
Granted: 66.065,38 Euros
Project Title: In vitro 3-D total cell guidance and fitness (COST Action CA16119 CellFit)
Financial Entity: COST Action CA16119
Lenght: 2017-2021
Principal Investigator: Tiziana Brevini
Working groups: WG1 3-D Cultures and Bioprinting; WG3 Chemobiological cues and Epigenetic controls
Countries: Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, fYR Macedonia, Germany, Greece, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Portugal, Serbia, Slovenia, Spain, Switzerland, Turkey, United Kingdom. The Cost includes two enterprises.
Granted: 580.000 Euros
Project Title: Genetic, transcriptomic and proteomic markers related to the evolution of hepatocarcinoma, co-morbidities and response to treatments (PI16/00090)
Financial Entity: Instituto de Salud Carlos III
Lenght: 2017-2019
Principal Investigator: Jordi Muntané Relat
Granted: 152.460 Euros
Project Title: Extracellular vesicle secretion and its relationship with the evolution of hepatocarcinoma, co-morbidities and response to treatments: Clinical and experimental study (PI-0198-2016)
Financial Entity: Consejería de Salud
Lenght: 2017-2019
Principal Investigator: Raul González Ojeda
Granted: 57.465,49 Euros
Project Title: Stratification of patients with hepatocarcinoma based on the detection and genetic and phenotypic analysis of CTCs: relationship with clinical evolution and response to treatment (PC-0522-2016-0043)
Financial Entity: Consejería de Salud
Lenght: 2017-2019
Principal Investigator: José María Álamo
Granted: 16.100 Euros
Project Title: European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)
Financial Entity: COST Action CA15138
Lenght: 2016-2020
Principal Investigator: Caty Casas
Working groups: WG1: Basic Research on Autophagy Molecular Machinery; WG4: Biomedical Research (iv Cancer).
Countries: Austria, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom. The Cost includes two enterprises.
Granted: 560.000 Euros
Project Title: Mitochondrial mapping: Evolution-Age-Gender-Lifestyle-Environment (MITOEAGLE)
Financial Entity: COST Action CA15203)
Lenght: 2016-2020
Principal Investigator: Erich Gnaiger
Working groups: TG3.2 Liver and TG4.2 Cultured cells.
Countries: Austria, Belgium, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, United Kingdom, Egipto. The Cost includes two enterprises.
Granted: 540.000 Euros